Holger Stark

An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain

A. Willuweit, Ian Gering, Dagmar Jürgens, 2023, British journal of pharmacology.

Progress on the development of Class A GPCR-biased ligands.

L. Wingler, P. Kozielewicz, Attila Egyed, 2024, British journal of pharmacology.